San Francisco, 9 January 2019: The Report Protein Engineering Market Analysis By Technology (Rational Protein Design,
Directed Evolution, Hybrid Approach), By Protein Type (Insulin, Monoclonal
Antibodies), By Product, By End-use, And Segment Forecasts, 2018 - 2025
The global protein engineering market is expected to reach USD 3.09 billion by 2025, according
to a new report by Grand View Research, Inc. The market is driven by presence
of regulatory authorities consistently striving to reduce time and cost
involved in the drug discovery process. One such example is the launch of
critical path initiative by U.S. FDA, for incorporation of advanced
technologies, such as protein engineering, in drug discovery processes.
Moreover, this facilitates prediction of probable adverse reactions &
toxicity and improves efficacy of target molecules early on, resulting in
lowered drug attrition rates in the later stages. This is anticipated to help
control overall expenditure. Rise in R&D expenditure by countries indicates
the urgent need for adoption of these tools in all drug discovery and
development processes.
The rising number of government initiatives
aimed at enhancing protein engineering capabilities is anticipated to present
the market with high growth potential. This has resulted in a significant rise
in number of research activities & programs and fund allotment for R&D.
For instance, Protein Engineering Network of Centres of Excellence (PENCE)
contributed approximately USD 1.0 million for proteomics projects and hosted
conferences on proteomics in Canada as an effort to broaden research associated
with this technology.
Access Research Report
of Protein Engineering Market @ www.grandviewresearch.com/industry-analysis/protein-engineering-market
Further Key Findings From the Report Suggest:
· Hybrid approach is predicted to observe
exponential growth as a consequence of technological superiority and ability to
overcome the shortcomings associated with the aforementioned technologies
· Software & services is expected to
emerge as the fastest growing segment owing to high inclination of companies to
outsourcing of services to achieve overall cost-efficiency
· Monoclonal antibodies held the largest
share in protein-type segment due to development of these antibodies on a large
scale through extensive adoption of these engineering tools
· North America held a substantial share,
which can be attributed to extensive research activities that are likely to
provide high potential growth platform through consistent usage in this region
· The market in Asia Pacific is projected to
exhibit exponential growth over the coming years owing to rising awareness
pertaining to benefits of protein engineering and increasing disposable income
· The competition is marked by players employing
strategies such as mergers & acquisitions and distribution agreements
resulting in significant growth in their market share
Browse more reports of this category by Grand View
Research at: www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the
global protein engineering market on the basis of technology, product, protein
type, end-use, and region:
Technology Outlook (Revenue, USD Million,
2014 - 2025)
·
Rational Protein Design
·
Directed Evolution
·
Hybrid Approach
Product Outlook (Revenue, USD Million, 2014
- 2025)
·
Instruments
·
Reagents
·
Software & Services
Protein Type Outlook (Revenue, USD Million,
2014 - 2025)
·
Insulin
·
Monoclonal Antibodies
·
Vaccines
·
Growth Factors
·
Colony Stimulating Factors
·
Coagulation Factors
·
Interferon
·
Others
End-use Outlook (Revenue, USD Million, 2014
- 2025)
·
Academic Research Institutes
·
CROs
·
Pharma & Biotech Companies
Regional Outlook (Revenue, USD Million,
2014 - 2025)
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
Middle East & Africa
Access Press Release of
Protein Engineering Market@ www.grandviewresearch.com/press-release/global-protein-engineering-market
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market intelligence
studies ensuring relevant and fact-based research across a range of industries,
from technology to chemicals, materials and healthcare.
No comments:
Post a Comment